A potential new treatment for neurodegenerative diseases
Neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), Parkinson’s disease (PD), Alzheimer’s disease (AD), and Huntington’s disease (HD), among others, are often associated with oxidative stress and neuroinflammation., In each of these diseases, there are similarities in the role of genetics, neurotransmitters, accumulation of toxic proteins, membrane damage, and mitochondrial dysfunction.,, Especially important among these parameters is the dysfunction of mitochondria and excess oxidative stress which can result in severe nerve cell dysfunction, reducing the number of cells in the brain and spinal cord by apoptosis (programmed cell death).,,, On a larger scale, this leads to the progressive and gradual loss of motor and cognitive function, the hallmark characteristics of neurodegenerative diseases. Treatment for these conditions is minimally successful at best, but emerging data suggests antioxidant agents may improve outcomes in neurodegenerative disorders through a reduction of oxidative stress and neuroinflammation,,,
Emerging data suggests antioxidant agents may improve outcomes in neurodegenerative disorders through a reduction of oxidative stress and neuroinflammation.
Molecular hydrogen (H2), a colorless, odorless, tasteless, non-toxic gas, is the lightest and most abundant element in the universe. Originally thought to be inert and non-functional, this basic molecule may be a potential solution to numerous pathologies that are largely due to oxidative stress and chronic inflammation.,, With more than 450 publications, reflecting over 170 different human and disease models, a broad range of clinical applications are beginning to surface – particularly in the realm of neurodegenerative disease.
Hydrogen’s “selective” antioxidant and anti-inflammatory properties
Oxidative stress and neuroinflammation are major contributing factors to central nervous system (CNS) disease such as dysfunction following brain injury, neurodegenerative disorders, psychiatric conditions, and other disease. Oxidative stress arises from the strong cellular damaging potential of excess reactive oxygen species (ROS).,, It is worth noting, however, that not all ROS are damaging to the body, and some are actually vital to physiological processes. For example, superoxide and hydrogen peroxide (H2O2) play important roles at low concentrations: they function as regulatory molecules that are involved in numerous signal transduction cascades and biological processes such as apoptosis and cell proliferation and differentiation., Nitric oxide (NO), another ROS, functions as a neurotransmitter and is essential for the dilation of blood vessels.
The hydroxyl radical (OH–), on the other hand, is one of the strongest of the oxidant species and reacts indiscriminately with nucleic acids, lipids, and proteins. Thus, scavenging this particular ROS is critical for the body, especially for many degenerative conditions. In an important study in 2007, Ohsawa et al. demonstrated that molecular H2, rather than being a strong reducing agent, is actually a weaker and more selective reducing agent., This means it reacts primarily with highly reactive and more toxic oxidants, leaving weaker (and biologically necessary) oxidants like NO and H2O2 present.
These and other characteristics of H2 are particularly important to the CNS for several reasons:
- The brain, compared to other organs, is particularly vulnerable to oxidative stress due to the fact that antioxidant defenses are relatively low despite its high oxygen consumption.,
- ROS are an important factor contributing to the development and progression of neurodegenerative diseases such as PD, AD, HD, ALS, and multiple sclerosis. ROS-induced mitochondrial damage, in particular, is associated with the onset of PD and AD.
- Because of its size, neutral charge, nonreactivity, and non-polarity, H2 readily passes through membranes (e.g., cellular membranes and the blood–brain barrier [BBB]), and into all cellular compartments and biological tissues (evidenced in part by its rapid appearance in the expired air from the lungs). This means it can reach not only the cytoplasm of the neurons in the brain, but also their nucleus, mitochondria, and other organelles – all of which are susceptible to damage and altered function due to the damaging effects of ROS.
Numerous preclinical studies have shown these properties of H2 may be beneficial for CNS disease and other pathologies. In 2007, research findings published in Nature Medicine showed that inhaled H2 substantially decreased damage to the brain associated with ischemia/reperfusion injury. In stressed cells, H2 dissolved in a cellular nutrient medium also was shown to be protective, reducing the amount of OH– radicals generated in both the cytoplasm and nucleus of the cells. It additionally was shown to protect the DNA from oxidation and cellular membranes from peroxidation, thus defending against apoptosis in a dose-dependent fashion.
The brain, compared to other organs, is particularly vulnerable to oxidative stress due to the fact that antioxidant defenses are relatively low despite its high oxygen consumption.
To further clarify the mechanism of H2’s effect in the brain, Sato et al. (2008) demonstrated that the administration of H2-rich water dramatically attenuated superoxide formation in the brain during hypoxia-reoxygenation treatment. (In excess, superoxide is damaging and may contribute to numerous diseases.) Authors of this study proposed that the decrease in superoxide may be due to the ability of H2 to readily permeate cellular membranes (including that of the mitochondria and nucleus), reducing superoxide production by the mitochondria and protecting DNA from damage by ROS, also influencing gene transcription.,,
Neuroinflammation occurs in a variety of physiological settings, such as infection, traumatic brain injury, toxin exposure, and autoimmunity. Although the CNS had been thought to be an immune-privileged site protected by the BBB, some cytokines and chemokines, such as interleukin (IL)-6, tumor necrosis factor (TNF)-alpha, and chemokine (C-C motif) ligand 2 (CCL2), are known to be transported across the BBB contributing to widespread neuroinflammation., Many of these mediators of inflammation also have been shown to increase BBB permeability – making a bad situation even worse.
What is interesting is that H2, in addition to its established antioxidant properties, can also function as an anti-inflammatory by down-regulating the expression of these and other pro-inflammatory factors.,,, H2 also has been shown to play an important role in blood vessel formation which is necessary for the growth of new neurons and the connections between them, – all things that are crucial for the healthy function and repair processes of the brain.
Alzheimer’s and Parkinson’s disease
Importantly, the CNS-protective effects of H2 shown in preclinical research translate to improvements seen clinically in neurodegenerative disease. A double-blind, placebo-controlled pilot study investigated the therapeutic efficacy of consuming 500 mL of H2-saturated water twice per day for 48 weeks in levodopa-medicated PD patients. A significant improvement in total UPDRS (Unified Parkinson’s Disease Rating Scale) scores for patients in the H2‐water group was demonstrated whereas UPDRS scores in the placebo group worsened, as is typical for a neurodegenerative condition such as PD. The consumption of H2‐saturated water was also safe and well tolerated. These promising findings have prompted a larger, multicenter 72-week study (not yet completed) investigating the impact of H2-rich water on this population.
Parkinson’s patients receiving 500 mL of H2-saturated water twice daily for 48 weeks had significant improvements in disease scores compared to placebo.
To further elucidate molecular H2’s potential role as a neuroprotective agent, Tan et al. (2018) reviewed the research concerning the role H2 may play in the pathological processes contributing to AD. In several animal models, treatment with H2-rich water had a favorable impact on cognition, memory, neuroplasticity, and over-all brain function.,,,, Consumption of H2 water prevented the decline of cognition, maintaining healthy levels of proliferation of neuronal progenitors, and inhibited oxidative stress after physical and mental stress in a mouse model of dementia. In an animal model of amyloid-beta-induced AD, treatment with H2-rich saline reduced neuroinflammation and oxidative stress, improving memory function. Another study concluded that consumption of H2 water for 30 days also prevented amyloid-beta induced neuroinflammation and oxidative stress, possibly by attenuation of activation of c-Jun NH2-terminal kinase (JNK) and nuclear factor-κB (NF-κB).
There have been promising results suggesting that treatment with H2-rich water may help reduce decline in humans with AD as well, at least in populations with a higher genetic risk of developing the disease. In a randomized double-blind placebo-controlled study, 73 subjects with mild cognitive impairment (MCI) drank approximately 300 mL of H2-water or placebo water per day, with the Alzheimer’s Disease Assessment Scale-cognitive subscale (ADAS-cog) scores assessed at baseline and after one year. Although the group as a whole didn’t show a significant improvement over the placebo group in the parameters assessed, the subpopulation within the group having the APOE4 genotype variant (an established genetic risk factor for AD) had significant improvements in their ADAS-cog scores as well as word recall scores.
In several animal models, treatment with H2-rich water had a favorable impact on cognition, memory, neuroplasticity, and over-all brain function.
Additional mechanism of action for molecular hydrogen
Another potential mechanism via which consumption of H2-rich water may deliver neuroprotective benefits also is worthy of mention. Ghrelin, a peptide hormone well known for its role in appetite and energy homeostasis, also has known neuroprotective effects. It has been demonstrated that the receptor for ghrelin, growth hormone secretagogue receptor (GHSR), is highly expressed by the dopaminergic neurons of the substantia nigra (a region of the brain that experiences loss of function in PD). Ghrelin has been shown to exert neuroprotective effects in PD by inhibiting activation of microglial cells (a type of immune cell in the CNS), reducing neuroinflammation and improving mitochondrial function.
In a study published by Matsumoto et al. (2013), it was demonstrated that H2-rich water induced gastric secretion of the hormone ghrelin. Further supporting this, it was shown that neuroprotective efficacy of H2 water was abolished by blocking activation of the ghrelin receptor (GHSR) and by blocking ghrelin secretion. Thus, findings that oral H2 water exerts a neuroprotective effect through activation of the endogenous gastric ghrelin system further supports the role molecular H2 may have in PD and other related neurodegenerative conditions.,,,
Findings that oral H2 water exerts a neuroprotective effect through activation of the endogenous gastric ghrelin system further supports the role molecular H2 may have in PD and other related neurodegenerative conditions.
Given molecular H2’s properties as a selective antioxidant and anti-inflammatory agent and its unique ability to diffuse into all regions of the cell and all tissues (including through the blood-brain barrier), a wide array of potential health benefits exist, particularly in conditions affecting the CNS. The rapidly growing body of research on this easily administered molecule clearly makes it an exciting therapeutic agent to study in all realms of physiology and disease.Click here to see References
 Emerit J, et al. Neurodegenerative diseases and oxidative stress. Biomed. Pharmacotherapy. 2004;58(1):39-46.
 Iketani M, et al. Molecular hydrogen as a neuroprotective agent. Curr Neuropharmacol. 2017 Feb;15(2):324–31.
 Lin M, et al. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 2006 Oct 19;443(7113):787-95.
 Vila M, et al. Targeting programmed cell death in neurodegenerative diseases. Nat Rev Neurosci. 2003 May;4(5):365-75.
 Pagano G, et al. Oxidative stress and mitochondrial dysfunction across broad-ranging pathologies: toward mitochondria-targeted clinical strategies. Oxid Med Cell Longev. 2014;2014:541230.
 Thompson L, et al. Neurodegeneration: a question of balance. Nature. 2008;452:707-8.
 Nicolson G, et al. Clinical effects of hydrogen administration: from animal and human diseases to exercise medicine. Int J Clin Med. 2016;7:32-76.
 Kovacs G, et al. Concepts and classification of neurodegenerative diseases. Handb Clin Neurol. 2017;145:301-7.
 Wang X, et al. Oxidative stress and mitochondrial dysfunction in Alzheimer’s disease. Biochem Biophys Acta. 2014;1842:1240-7.
 Hald A, et al. Oxidative stress and inflammation in Parkinson’s disease: is there a causal link? Exp Neurol. 2005;193:279-90.
 Moosmann B, et al. Antioxidants as treatment for neurodegenerative disorders. Expert Opin Investig Drugs. 2002;11:1407-35.
 Dania C, et al. The discovery and development of new potential antioxidant agents for the treatment of neurodegenerative diseases. Expert Opin Drug Discov. 2014;9:1205-22.
 Ohno K, et al. Molecular hydrogen as an emerging therapeutic medical gas for neurodegenerative and other diseases. Oxid Med Cell Longev. 2012:353152.
 Ge L, et al. Molecular hydrogen: a preventative and therapeutic medical gas for various diseases. Oncotarget. 2017;Sep 21;8(60):102653-73.
 Ichihara M, et al. Beneficial biological effects and the underlying mechanisms of molecular hydrogen – comprehensive review of 321 original articles. Med Gas Res. 2015; Oct 19;5:12.
 Wallace D.C, et al. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer; a dawn for evolutionary medicine. Annu. Rev. Genet. 2005;39:359-407.
 Reddy P, et al. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer’s disease. J Neurochem. 2006;96:1-13.
 Saur H, et al. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem. 2001;11:173-86.
 Lie H, et al. Redox-dependent transcriptional regulation. Circ Res. 2005;97:967-74.
 Murad F, et al. Discovery of some of the biological effects of nitric oxide and its role in cell signaling. Biosci Rep. 2004;24:452-74.
 Sheu S, et al. Targeting antioxidants to mitochondria: a new therapeutic direction. Biochem Biophys. 2006;1762:256-65.
 Ohsawa I, et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med. 2007 Jun;13(6):688-94.
 Matei N, et al. Emerging mechanisms and novel applications of hydrogen gas therapy. Med Gas Res. 2018 Sep 25;8(3):98-102.
 Ames B, et al. Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science. 1983;221(4617):1256-64.
 Rice-Evans C, et al. Free radical-lipid interactions and their pathological consequences. Prog Lipid Res. 1993;32(1):71-110.
 Qian L, et al. Methods of hydrogen application. In: Sun X, Ohta S, Nakao S, eds. Hydrogen Molecular Biology and Medicine. Dordrecht, Netherlands: Springer; 2015.
 Sato Y, et al. Hydrogen-rich pure water prevents superoxide formation in the brain slices of vitamin C-depleted SMP30/GNL knockout mice. Biochem Biophys Res Commun. 2008;375:346-50.
 Shirahata S, et al. Electrolyzed-reduced water scavenges active oxygen species and protects DNA from oxidative damage. Biochem Biophys Res Commun. 1997:269-74.
 Gendelman H.E. Neural immunity: friend or foe? J Neurovirol. 2002;8(6):474–9.
 Wilson H, et al. Trafficking of immune cells in the central nervous system. J. Clin. Invest. 2010;120(5):1368–79.
 Banks W, et al. The blood-brain barrier in neuroimmunology: tales of separation and assimilation. Brain Behav Immun. 2015;44:1–8.
 Farkas G, et al. Experimental acute pancreatitis results in increased blood-brain barrier permeability in the rat: a potential role for tumor necrosis factor and interleukin 6. Neurosci Lett. 1998 Feb 20;242(3):147-50.
 Ge L, et al. Molecular hydrogen: a preventative and therapeutic medical gas for various diseases. Oncotarget. 2017;8:102653-73.
 Ohta S, et al. Molecular hydrogen as a preventive and therapeutic medical gas: initiation, development and potential of hydrogen medicine. Pharmacol Ther. 2014;144(1):1–11.
 Chen C, et al. Hydrogen gas reduced acute hyperglycemia-enhanced hemorrhagic transformation in a focal ischemia rat model. Neuroscience. 2010;169(1):402–14.
 Buchholz B, et al. Hydrogen inhalation ameliorates oxidative stress in transplantation induced intestinal graft injury. Am J Transplant. 2008;8(10):2015–24.
 Ergul A, et al. Angiogenesis: a harmonized target for recovery after stroke. Stroke J Cereb Circ. 2012;43:2270-4.
 Papapetropoulos A, et al. Hydrogen sulfide is an endogenous stimulator of angiogenesis. Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21972-7.
 Yoritaka A, et al. Pilot study of H2 therapy in Parkinsons disease: a randomized double-blind placebo-controlled trial. Mov. Disord. 2013;28(6):836–9.
 Yoritaka A, et al. A randomized double-blind multi-center trial of hydrogen water for Parkinson’s disease: protocol and baseline characteristics. BMC Neurol. 2016 May 12;16:66.
 Tan X, et al. The role of hydrogen in Alzheimer’s disease. Med Gas Res. 2018;Oct-Dec;8(4):176-80.
 Hald A, Lotharius J. Oxidative stress and inflammation in Parkinson’s disease: is there a causal link? Exp Neurol. 2005;193:279-90.
 Luquecontreras D, et al. Oxidative stress and metabolic syndrome: cause or consequence of Alzheimer’s disease? Oxid Med Cell Longev. 2015;2014:497802.
 Nagata K, et al. Consumption of molecular hydrogen prevents the stress-induced impairments in hippocampus-dependent learning tasks during chronic physical restraint in mice. Neuropsychopharmacology. 2009;34:501-8.
 Le J, et al. Hydrogen-rich saline improves memory function in a rat model of amyloid-beta induced Alzheimer’s disease by reduction of oxidative stress. Brain Res. 2010;1328:152-61.
 Gu Y, et al. Drinking hydrogen water ameliorated cognitive impairment in senescence-accelerated mice. J Clin Biochem Nutr. 2010;46:269-76.
 Nishimaki K, et al. Effects of molecular hydrogen assessed by an animal model and a randomized clinical study on mild cognitive impairment. Curr Alzheimer Res. 2018;15:482-92.
 Safieh M, et al. ApoE4: an emerging therapeutic target for Alzheimer’s disease. BMC Med. 2019 Mar 20;17(1):64.
 Andrews Z, et al. The extra-hypothalamic actions of ghrelin on neuronal function. Trends Neurosci. 2011;34:31-40.
 Zigman, J, et al. Expression of ghrelin receptor mRNA in the rat and mouse brain. J Comp Neurol. 2006;494:528-48.
 Bayliss JA, Andrews ZB. Ghrelin is neuroprotective in Parkinson’s disease: molecular mechanisms of metabolic neuroprotection. Ther Adv Endocrinol Metab. 2013 Feb;4(1):25-36.
 Matsumoto A, et al. Oral ‘hydrogen water’ induces neuroprotective ghrelin secretion in mice. Sci Rep. 2013;3:3273.